• 45 Investors
  • Longevity in China
1. .406 Ventures 2005
2. Amphora Capital 1
3. BioVeda China Fund 2005
4. Cenova Ventures
5. China Bridge Capital 2004
6. China Capital Zhongcai Fund Management 2013
7. China Life Healthcare Fund 2007
8. China Materialia 2010
9. China Medical System Holdings Limited 1995
10. Fosun Group 1992
11. GEOC
12. GIBF Fund
13. GoldStone Investment 2007
14. GP Healthcare Capital 0
15. Green Pine Innovation 2015
16. Haisco 2000
17. Hakim Unique Internet 2002
18. Hantan Capital
19. Harvest Fund Management 1
20. Health 100 2004
21. Hillhouse Capital Management 2005
22. HNF 2013
23. Horizons Ventures Limited 1999
24. Huangpu River Capital 2015
25. Huawei Technologies 1
26. Jiantou Huawen Investment 2013
27. Jilin Zhongke Bio-Engineering 14
28. Joy Capital 2015
29. Leaguer Venture Capital 1
30. Lepu Medical 1
31. Luye Medical Group Co., Ltd
32. Milestone Capital China 2002
33. NetEase 1
34. Paul Capital 1991
35. Peacock Capital 1970
36. Shanghai Fosun Pharmaceutical (Group) Co.,Ltd 1994
37. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 1994
38. Shengjing Group
39. Shu Duan
40. Startupbootcamp Digital Health Chengdu
41. TAL Education Group 1
42. Tasly Pharmaceutical 1994
43. Tianjin Pharmaceutical Group International Holdings
44. Tusholdings 1
45. Wandai Capital

«Longevity in China»

  • — investor and funding support bodies
  • — hubs and other organisation types

Industries

AI
AgeTech
Asset Management
Biotechnology, Health Care, Medical
Biotechnology, Pharmaceutical
Financial Services
Financial Services, Impact Investing, Venture Capital
Financial Services, Lending and Investments
Health Care
Health Care, Health Diagnostics, Medical
Healthcare
Information and Communications Technology (ICT)
Internet Services, Other, Professional Services, Real Estate, Software
Investor
Longevity Industry 2022
Manufacturing
Neurotech
Personalized Medicine
Precision Medicine
Preventive Medicine
Regenerative Medicine
mHealth
mHealth investor
test_custom_domain_2
© 2026